Introduction
Hypogonadism is diagnosed when the body’s gonads, the testes in males or the ovaries in females, do not produce enough sex hormones or do not produce enough sperm or eggs as expected. In clinical practice, diagnosis is not based on a single symptom or one lab value. It is established through a combination of symptoms, physical findings, hormone measurements, and, when needed, additional testing to determine whether the problem originates in the gonads themselves or in the brain regions that regulate them.
Accurate diagnosis matters because hypogonadism can reflect several different biological problems, including primary gonadal failure, pituitary disease, hypothalamic disorders, genetic conditions, medication effects, chronic illness, or normal age-related change. The cause determines treatment and also affects whether the condition is reversible, progressive, or associated with other endocrine disorders.
Recognizing Possible Signs of the Condition
Clinicians usually begin to suspect hypogonadism when symptoms suggest reduced sex hormone activity or impaired reproductive function. In males, this may include reduced libido, erectile dysfunction, decreased morning erections, infertility, reduced facial or body hair, loss of muscle mass, fatigue, low bone density, or delayed puberty in adolescents. In females, possible signs include absent or irregular menstrual periods, infertility, hot flashes, vaginal dryness, reduced libido, and delayed or absent puberty. In children and adolescents, slowed growth, delayed sexual development, or failure to progress through expected pubertal stages may be the first clues.
The pattern of symptoms gives important diagnostic clues. For example, symptoms that begin after normal puberty suggest acquired hypogonadism, while absent puberty suggests a developmental or congenital disorder. Severe fatigue and nonspecific symptoms can occur in many illnesses, so doctors look for reproductive and physical signs that point more specifically to low sex steroid activity or reduced gamete production.
Biologically, hypogonadism matters because sex hormones such as testosterone and estradiol regulate not only reproduction but also bone metabolism, muscle maintenance, fat distribution, and aspects of neurocognitive and sexual function. A decline in these hormones can therefore affect multiple body systems, which is why the condition may be suspected from a broad range of clinical changes.
Medical History and Physical Examination
The diagnostic process begins with a detailed medical history. A clinician asks when symptoms started, whether they are constant or intermittent, and whether puberty, menstrual cycles, sexual function, fertility, or growth have changed over time. In males, questions often focus on libido, erectile function, fertility history, testicular development, and timing of puberty. In females, history usually includes menstrual regularity, age at menarche, fertility, and symptoms of estrogen deficiency. In younger patients, growth patterns and pubertal milestones are central.
Past medical history is also important. Doctors review prior chemotherapy or radiation, testicular injury or surgery, pituitary disease, head trauma, pituitary tumors, autoimmune disease, chronic kidney disease, liver disease, obesity, diabetes, obstructive sleep apnea, infections such as mumps orchitis, and genetic disorders. Medication review is essential because opioids, glucocorticoids, anabolic steroids, some psychiatric medications, and certain cancer therapies can suppress the hypothalamic-pituitary-gonadal axis or directly damage gonadal tissue.
Family history may reveal inherited causes, especially when there is delayed puberty, infertility, anosmia, or known chromosomal conditions. Social history matters as well because excessive exercise, eating disorders, severe stress, or substance use can suppress reproductive hormone production.
Physical examination helps determine whether low hormone production is likely and whether the cause appears to be primary or central. In males, clinicians assess testicular size and consistency, body hair, muscle mass, gynecomastia, and the presence of signs of delayed puberty. Small, firm testes can suggest primary testicular failure, while normal or small testes with other signs of pituitary or hypothalamic dysfunction may suggest central hypogonadism. In females, the exam may look for signs of estrogen deficiency, such as vaginal mucosal dryness or lack of secondary sexual development, as well as evidence of androgen excess or other endocrine disorders.
Doctors may also look for features suggesting a broader pituitary problem, such as visual field abnormalities, headaches, galactorrhea, thyroid enlargement, low blood pressure, or changes in weight and skin texture. These findings help decide which laboratory and imaging studies are needed next.
Diagnostic Tests Used for Hypogonadism
Laboratory testing is the core of diagnosis. The main purpose is to measure the relevant sex hormones and determine whether the hypothalamus, pituitary gland, or gonads are failing to function normally. In males, serum total testosterone is usually the first test, typically measured in the morning when levels are highest. Because testosterone varies with time of day, illness, and sleep, a low result usually needs confirmation with a repeat morning level. If total testosterone is borderline or if conditions such as obesity, aging, or liver disease may alter sex hormone-binding globulin, clinicians may order free testosterone or calculate it from binding protein levels.
Once low testosterone is confirmed, luteinizing hormone and follicle-stimulating hormone are measured. These pituitary hormones show whether the brain is appropriately signaling the testes. High LH and FSH with low testosterone suggest primary hypogonadism, meaning the testes are not responding adequately. Low or inappropriately normal LH and FSH with low testosterone suggest secondary or central hypogonadism, meaning the hypothalamus or pituitary is underfunctioning.
In females, diagnosis depends on the clinical context. Estradiol is often assessed along with LH and FSH, especially when amenorrhea, delayed puberty, or infertility is present. Elevated FSH and LH with low estradiol typically indicate ovarian failure, whereas low or normal gonadotropins with low estradiol point toward hypothalamic or pituitary dysfunction. In both sexes, prolactin may be measured because hyperprolactinemia can suppress gonadotropin release and mimic hypogonadism.
Other blood tests often help identify underlying causes or complications. Thyroid function tests, iron studies, complete blood count, metabolic panel, liver and kidney function tests, and sometimes cortisol or insulin-like growth factor 1 may be ordered depending on the context. If genetic or developmental causes are suspected, karyotyping or specific genetic testing may be used. For example, karyotyping can identify conditions such as Klinefelter syndrome in males or Turner syndrome in females.
Imaging studies are used when central hypogonadism is suspected or when exam findings suggest pituitary or hypothalamic disease. Magnetic resonance imaging of the brain, particularly the pituitary region, can detect tumors, infiltrative disease, congenital abnormalities, or other structural lesions. In adolescents with delayed puberty, bone age x-rays may be used to see whether skeletal maturation is delayed, which helps distinguish constitutional delay from pathologic hypogonadism.
Functional tests may be used in selected cases. A gonadotropin-releasing hormone stimulation test can help assess the capacity of the pituitary to release LH and FSH, especially in complex pediatric cases. Semen analysis is a functional test in men when infertility is a concern; it evaluates sperm count, motility, and morphology and can reveal impaired testicular function even when hormone results are borderline. In women, ovulation assessment may include progesterone measurement, menstrual tracking, or fertility-focused testing depending on the clinical question.
Tissue examination is not routine but may be important when a mass, tumor, or infiltrative process is suspected. Biopsy or histologic evaluation may be performed if imaging shows a suspicious lesion in the pituitary, testes, or ovaries, or if surgical treatment is planned. In primary testicular disorders, tissue findings can clarify whether the problem is due to degeneration, inflammation, genetic abnormalities, or damage from chemotherapy or infection.
Interpreting Diagnostic Results
Doctors interpret results by combining hormone patterns with the clinical picture. A single low hormone value does not automatically confirm hypogonadism, because transient suppression can occur during acute illness, undernutrition, heavy exercise, sleep disruption, or medication use. Confirmation usually requires repeat testing and correlation with symptoms.
The key interpretive step is distinguishing primary from secondary hypogonadism. In primary hypogonadism, the gonads fail to produce adequate sex steroids or gametes, so the pituitary responds by increasing LH and FSH. In secondary hypogonadism, the hypothalamus or pituitary fails to provide sufficient stimulation, so LH and FSH are low or inappropriately normal despite low sex steroid levels. This distinction guides the next steps in evaluation and management.
Doctors also interpret results in context. Mild testosterone reduction in an older man with obesity and chronic disease may reflect functional suppression rather than irreversible gonadal failure. In a young man with infertility and small testes, the same test result may suggest a genetic or primary testicular disorder. In females, interpretation depends on age, menstrual status, menopausal stage, pregnancy possibility, and the timing of blood collection relative to the cycle.
When laboratory findings are ambiguous, repeat testing, specialist referral, or expanded endocrine evaluation is often needed. The diagnosis is considered secure when symptoms, examination, and repeated biochemical evidence consistently show inadequate gonadal hormone production or inadequate gonadotropin signaling.
Conditions That May Need to Be Distinguished
Several disorders can resemble hypogonadism because they share symptoms such as fatigue, low libido, infertility, menstrual irregularity, or delayed development. One important distinction is between hypogonadism and general chronic illness. Conditions such as severe obesity, diabetes, chronic inflammation, kidney disease, liver disease, and sleep apnea can lower sex hormone levels without a primary gonadal defect. Treating the underlying illness may improve hormone function.
Thyroid disorders can also mimic aspects of hypogonadism. Hypothyroidism may cause fatigue, menstrual irregularity, and reduced sexual function, while hyperthyroidism can disrupt menstrual cycles and fertility. Depression, anxiety, and medication side effects can produce symptoms that overlap with androgen or estrogen deficiency, so clinicians must evaluate the broader clinical context.
In males, erectile dysfunction may be caused by vascular disease, diabetes, neurologic disease, medication effects, or psychological factors even when testosterone is normal. Infertility can result from obstruction of the reproductive tract, varicocele, or sperm production problems that are not due to hormone deficiency. In females, amenorrhea may result from pregnancy, polycystic ovary syndrome, hypothalamic amenorrhea, premature ovarian insufficiency, or pituitary disease. Distinguishing these conditions requires targeted testing and careful history.
Pubertal delay can also be mistaken for hypogonadism. Constitutional delay of growth and puberty is a normal variant in some adolescents and may resemble pathologic central hypogonadism. Bone age assessment, family history, growth pattern, and serial follow-up help separate delayed but otherwise normal maturation from true endocrine disease.
Factors That Influence Diagnosis
Several factors affect how hypogonadism is diagnosed and how confidently it can be confirmed. Age is important because hormone levels naturally change across the lifespan. Testosterone declines gradually with aging in many men, and menopause causes expected ovarian hormone decline in women. Clinicians must decide whether the hormone pattern is physiologic for age or abnormal enough to indicate disease.
Severity and timing of symptoms also matter. Long-standing, severe, or progressive symptoms are more suggestive of true endocrine dysfunction than isolated or nonspecific complaints. In children and adolescents, the timing of growth and pubertal milestones can be more informative than absolute hormone levels alone.
Associated conditions can alter both symptoms and test interpretation. Obesity lowers sex hormone-binding globulin and may reduce measured total testosterone without necessarily indicating severe androgen deficiency. Acute illness can temporarily suppress the hypothalamic-pituitary-gonadal axis. Medications may interfere with hormone production or alter binding proteins. Pregnancy, oral estrogen therapy, and hormonal contraceptives can also change expected results, especially in females.
Ethnic, genetic, and developmental factors may influence the evaluation as well. Some patients have congenital syndromes with broader endocrine or nonendocrine findings, so diagnosis may require genetic testing and specialist assessment. In infertility workups, the diagnostic threshold may be lower because subtle hormone abnormalities can still affect reproductive function.
Conclusion
Hypogonadism is diagnosed through a structured medical evaluation that combines symptom review, physical examination, hormone testing, and targeted studies to identify the cause. Clinicians first look for reproductive, sexual, developmental, and systemic signs that suggest inadequate sex hormone production or impaired gonadal function. They then use morning hormone measurements, gonadotropins, and other laboratory tests to determine whether the defect is primary or central. Imaging, functional studies, and occasional tissue examination are used when the history, examination, or blood work suggests pituitary disease, genetic disorders, or structural damage.
The diagnosis is not made from symptoms alone and is rarely based on a single abnormal result. Instead, medical professionals confirm hypogonadism by integrating the pattern of hormone abnormalities with the patient’s age, health conditions, reproductive history, and physical findings. This approach allows them to identify the condition accurately and to distinguish it from other disorders that may look similar but require different treatment.